|
Drugs in Context 2012
Is ‘GOLD’ standard for the management of COPD in clinical practice?DOI: 10.7573/dic.212243 Keywords: chronic bronchitis , COPD , emphysema , exacerbations , FEV1 , formoterol , FVC , GOLD , immunization , indacaterol , LABA , LAMA , LTRA , methylxanthines , respimat , roflumilast , SGRQ , tiotropium , TORCH , UPLIFT Abstract: Summary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable.
|